Inflammatory Bowel Disease Research
The Mater Inflammatory Bowel Disease Research Group’s collective emphasis on clinical translational research using a multi-disciplinary, highly collaborative, patient focused approach enables the integration of commercial and academic research with exceptional patient care.
The Research Group is focused on advancing innovative, preventative and therapeutic approaches to treating gut inflammation.
The Group's vision is to revolutionise clinical practice by leading in clinical and translational research at the intersection of the microbiome, inflammation and gut health.
Group Leaders
![](/kenticoimage.axd/media/3bd5e59a-6581-4d08-b3aa-f810a6e97545/2024_MR_IBD-program-Rabina-1.png?width=900&height=600&rmode=crop&d=123618&hmac=e7b4d61c5fd314bcc38bcaccb69df9fbdb61d0c30a08c8b17459b93e75fb960a)
Group members
Group Leader Associate Professor Jake Begun and Clinical Lead Dr Yoon-Kyo An are supported by clinical trials group members and translational researchers.
Clinical Trials Investigators
- Dr Emi Khoo (Clinical PhD candidate)
- Dr Richard Fernades (Clinical PhD candidate)
- Dr Robert Gilmore (Clinical PhD candidate)
- Dr Myat Khaing
- Dr Mariko Howlett
Clinical Trials Team
- Ms Sharyn Grossman
- Ms Natalie Allan
- Ms Deborah Gietzel
- Ms Jessica Bonner
- Ms Niamh Lindsay
- Ms Thy Pham
- Ms Ashely Tan
Translational Lab Team
- Dr Anna Amiss
Dr Rabina Giri